A major trial emulation study published in the Annals of Internal Medicine challenges the standard approach to managing moderate cervical dysplasia. Researchers found that women with cervical intraepithelial neoplasia grade 2 (CIN 2) who delayed excision for up to six months experienced no increased cervical cancer risk at three years compared to those treated immediately.
The finding has significant implications for clinical practice. By deferring immediate treatment in selected cases, the study demonstrates that thousands of women could be spared from unnecessary invasive procedures annually without compromising safety. These results suggest that individualized risk stratification, rather than automatic excision, may be a more prudent and cost-effective approach to managing moderate cervical dysplasia.
The discovery is expected to reshape international gynecological practice guidelines and encourage clinicians to adopt more nuanced management strategies tailored to patient-specific risk profiles.
Was this article helpful?
